Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 6:31 PM
Ignite Modification Date:
2025-12-24 @ 6:31 PM
NCT ID:
NCT00004557
Eligibility Criteria:
Subjects will include:
Patients assigned a diagnosis of probable Alzheimer's disease meeting NINCDS-ADRDA and DSM-III-R criteria.
Patients with other neuropsychiatric illness (i.e., depression, Korsakoff's disease, Huntington's disease).
Normal controls.
Subjects must not have major concomitant illness.
All patients will be drug-free for at least 2 weeks whenever possible. Concurrent use of some medications (i.e., diuretics or antibiotics) will be allowed only after careful review by the investigators.
Normal control subjects will be without a history of or present psychiatric or neurological illness.
Healthy Volunteers:
True
Sex:
ALL
Study:
NCT00004557
Study Brief:
Protocol Section:
NCT00004557